CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3027% below fair value
$49.35−1.24 (-2.45%)
Close on Nov 16, 2026Market cap $1.47BP/E 20.4Yield 1.22%
Conmed EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Conmed's EV/EBITDA was 21.4× on Nov 11, 2026, against 18.3× a year earlier. Over the last 5 years it ranged from 12.0× to 86.3×, with a median of 23.6×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 21.4× | +3.8 |
| 2025 | Dec 31, 2025 | 17.5× | +2.2 |
| 2024 | Dec 31, 2024 | 15.4× | −48.2 |
| 2023 | Dec 29, 2023 | 63.6× | +28.0 |
| 2022 | Dec 30, 2022 | 35.6× | −18.2 |
| 2021 | Dec 31, 2021 | 53.8× | −28.2 |
| 2020 | Dec 31, 2020 | 82.0× | +29.6 |
| 2019 | Dec 31, 2019 | 52.4× | +19.3 |
| 2018 | Dec 31, 2018 | 33.1× | −19.0 |
| 2017 | Dec 29, 2017 | 52.1× | +7.3 |
| 2016 | Dec 30, 2016 | 44.8× | +19.1 |
| 2015 | Dec 31, 2015 | 25.7× | −2.0 |
| 2014 | Dec 31, 2014 | 27.7× | +3.7 |
| 2013 | Dec 31, 2013 | 24.0× | −120.3 |
| 2012 | Dec 31, 2012 | 144.3× | +130.6 |
| 2011 | Dec 30, 2011 | 13.7× | −13.2 |
| 2010 | Dec 31, 2010 | 26.9× | – |
See a number that looks wrong?